4.7 Article

What level of D-dimers can safely exclude pulmonary embolism in COVID-19 patients presenting to the emergency department?

Journal

EUROPEAN RADIOLOGY
Volume 32, Issue 4, Pages 2704-2712

Publisher

SPRINGER
DOI: 10.1007/s00330-021-08377-9

Keywords

Pulmonary embolism; COVID-19 pandemic; Angiography; computed tomography; Pulmonary thromboembolism; Diagnostic technics and procedures

Ask authors/readers for more resources

This study aimed to identify the D-dimer levels that would allow the safe exclusion of pulmonary embolism (PE) in COVID-19 patients presenting to the emergency department. The results showed that the D-dimer levels were significantly higher in patients with PE compared to those without PE. Using specific D-dimer thresholds, PE could be safely ruled out and the number of unnecessary CTPA scans could be reduced.
Objectives To identify which level of D-dimer would allow the safe exclusion of pulmonary embolism (PE) in COVID-19 patients presenting to the emergency department (ED). Methods This retrospective study was conducted on the COVID database of Assistance Publique - Hopitaux de Paris (AP-HP). COVID-19 patients who presented at the ED of AP-HP hospitals between March 1 and May 15, 2020, and had CTPA following D-dimer dosage within 48h of presentation were included. The D-dimer sensitivity, specificity, and positive and negative predictive values were calculated for different D-dimer thresholds, as well as the false-negative and failure rates, and the number of CTPAs potentially avoided. Results A total of 781 patients (mean age 62.0 years, 53.8% men) with positive RT-PCR for SARS-Cov-2 were included and 60 of them (7.7%) had CTPA-confirmed PE. Their median D-dimer level was significantly higher than that of patients without PE (4,013 vs 1,198 ng center dot mL(-1), p < 0.001). Using 500 ng center dot mL(-1), or an age-adjusted cut-off for patients > 50 years, the sensitivity and the NPV were above 90%. With these thresholds, 17.1% and 31.5% of CTPAs could have been avoided, respectively. Four of the 178 patients who had a D-dimer below the age-adjusted cutoff had PE, leading to an acceptable failure rate of 2.2%. Using higher D-dimer cut-offs could have avoided more CTPAs, but would have lowered the sensitivity and increased the failure rate. Conclusion The same D-Dimer thresholds as those validated in non-COVID outpatients should be used to safely rule out PE.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)

Silvia Sartorelli, Guillaume Chassagnon, Pascal Cohen, Bertrand Dunogue, Xavier Puechal, Alexis Regent, Luc Mouthon, Loic Guillevin, Benjamin Terrier

Summary: Specific cardiomyopathy is frequent in EGPA, especially in ANCA-negative patients with high eosinophil counts. Long-term outcome was better than previously reported. Abnormal ECG and LGE on CMRI were associated with the occurrence of MACEs.

RHEUMATOLOGY (2022)

Letter Respiratory System

Diversity of approaches in artificial intelligence: an opportunity for discoveries in thoracic imaging

Guillaume Chassagnon, Alienor Campredon, Maria Vakalopoulou, Pierre-Regis Burgel

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Respiratory System

Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis

Alienor Campredon, Enzo Battistella, Clemence Martin, Isabelle Durieu, Laurent Mely, Christophe Marguet, Chantal Belleguic, Marlene Murris-Espin, Raphael Chiron, Annlyse Fanton, Stephanie Bui, Martine Reynaud-Gaubert, Philippe Reix, Trieu-Nghi Hoang-Thi, Maria Vakalopoulou, Marie-Pierre Revel, Jennifer Da Silva, Pierre-Regis Burgel, Guillaume Chassagnon

Summary: The study evaluated lung structural changes after 1 year of lumacaftor-ivacaftor treatment and identified morphological phenotypes associated with treatment response using unsupervised machine learning. The results showed significant improvement in bronchial disease on chest CT after 1-year treatment with lumacaftor-ivacaftor, and radiomics features on pre-therapeutic CT scans may help predict lung function response to the medication.

EUROPEAN RESPIRATORY JOURNAL (2022)

Letter Critical Care Medicine

Change in Lung Function after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Do Not Forget Anatomy!

Clemence Martin, Lucile Regard, Guillaume Chassagnon, Pierre-Regis Burgel

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Letter Radiology, Nuclear Medicine & Medical Imaging

Risk of pleural and diaphragmatic complications following percutaneous radiofrequency ablation of basal lung nodules

Arnaud Tual, Marie-Pierre Revel, Emma Canniff, Alexandre Garin, Guillaume Chassagnon

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2022)

Review Pharmacology & Pharmacy

The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications

Philippe Icard, Luca Simula, Ludovic Fournel, Karen Leroy, Audrey Lupo, Diane Damotte, Marie Christine Charpentier, Catherine Durdux, Mauro Loi, Olivier Schussler, Guillaume Chassagnon, Antoine Coquerel, Hubert Lincet, Vincent De Pauw, Marco Alifano

Summary: NSCLC is the main cause of cancer mortality and poses a significant challenge in cancer therapy. Resistance to anticancer drugs is promoted by hypoxia and HIF-1?? in tumor cells. Chemoresistance is also influenced by the activation of various oncogenic signaling pathways.

DRUG RESISTANCE UPDATES (2022)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Does artificial intelligence surpass the radiologist?

Philippe Soyer, Elliot K. Fishman, Steven P. Rowe, Michael N. Patlas, Guillaume Chassagnon

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2022)

Letter Radiology, Nuclear Medicine & Medical Imaging

Pulmonary vein occlusion with parenchymal infarction: A misdiagnosed entity

Elodie Gouhier, Emma Canniff, Ludovic Fournel, Marie-Pierre Revel, Guillaume Chassagnon

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2022)

Review Health Care Sciences & Services

How Artificial Intelligence in Imaging Can Better Serve Patients with Bronchial and Parenchymal Lung Diseases?

Trieu-Nghi Hoang-Thi, Guillaume Chassagnon, Hai-Dang Tran, Nhat-Nam Le-Dong, Anh Tuan Dinh-Xuan, Marie-Pierre Revel

Summary: Artificial intelligence plays a significant role in medicine and lung health by enabling automatic quantitative assessment of anatomical structures and disease detection/prognosis estimation through machine learning.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Artificial intelligence in lung cancer: current applications and perspectives

Guillaume Chassagnon, Constance De Margerie-Mellon, Maria Vakalopoulou, Rafael Marini, Trieu-Nghi Hoang-Thi, Marie-Pierre Revel, Philippe Soyer

Summary: AI has been widely applied in thoracic oncology, including pulmonary nodule detection, segmentation, characterization, and stratification. Some of the tools developed have already been commercially available.

JAPANESE JOURNAL OF RADIOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Artificial intelligence: A critical review of applications for lung nodule and lung cancer

Constance de Margerie-Mellon, Guillaume Chassagnon

Summary: Artificial intelligence has been applied in medical imaging, specifically in the detection, segmentation, and classification of lung nodules, as well as the characterization and prognosis prediction of lung cancer. However, the clinical implementation of AI tools is still in its early stages due to the lack of generalizability in published studies, limited understanding of the working mechanism, and insufficient data on the impact on radiologists' decision-making and patient outcomes.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2023)

Article Oncology

Assessment of Functional and Nutritional Status and Skeletal Muscle Mass for the Prognosis of Critically Ill Solid Cancer Patients

Clara Vigneron, Othmane Laousy, Guillaume Chassagnon, Maria Vakalopoulou, Julien Charpentier, Jerome Alexandre, Matthieu Jamme, Frederic Pene

Summary: This study evaluated the impact of daily activities, nutritional status, and muscle surface on the prognosis of critically ill cancer patients in the intensive care unit (ICU). The results showed that muscle surface, the ability to perform daily activities, and the six-month course of nutritional parameters could predict short- and long-term prognosis. This information is crucial for solid cancer patients with life-threatening complications.

CANCERS (2022)

Article Rheumatology

Differentiating tracheobronchial involvement in granulomatosis with polyangiitis and relapsing polychondritis on chest CT: a cohort study

Carole Jalaber, Xavier Puechal, Ines Saab, Emma Canniff, Benjamin Terrier, Luc Mouthon, Eglantine Cabanne, Sandra Mghaieth, Marie-Pierre Revel, Guillaume Chassagnon

Summary: Chest CT can differentiate between GPA and RP, with subglottic tracheal involvement and extensive airway involvement being the most relevant features.

ARTHRITIS RESEARCH & THERAPY (2022)

No Data Available